Results 101 to 110 of about 2,785 (177)

Double dosing ulipristal acetate emergency contraception for individuals with obesity: a randomised crossover trial. [PDF]

BMJ Sex Reprod Health
Edelman A, Hennebold JD, Bond K, Lim JY, Cherala G, Blue SW, Kraft SP, Erikson DW, Archer D, Jensen J.   +9 more
europepmc   +1 more source

Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: An exploratory study. [PDF]

Contraception
Gawron LM, Kaiser JE, Gero A, Sanders JN, Johnstone EB, Turok DK.   +5 more
europepmc   +1 more source

Latin American and Caribbean countries’ baseline clinical and policy guidelines for responding to intimate partner violence and sexual violence against women [PDF]

, 2015

core   +1 more source

Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel. [PDF]

Contraception
Edelman A, Jensen JT, Brown J, Thomas M, Archer DF, Schreiber CA, Teal S, Westhoff C, Dart C, Blithe DL.   +9 more
europepmc   +1 more source

Predictive Factors of Response to Selective Progesterone Receptor Modulator (Ulipristal Acetate) in the Pharmacological Treatment of Uterine Fibroids. [PDF]

Int J Environ Res Public Health, 2020
Szydłowska I, Marciniak A, Nawrocka-Rutkowska J, Rył A, Starczewski A.   +4 more
europepmc   +1 more source

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic! [PDF]

Eur J Obstet Gynecol Reprod Biol, 2020
Rozenberg S, Revercez P, Fastrez M, Vandromme J, Bucella D.   +4 more
europepmc   +1 more source

Therapy with Ulipristal Acetate in a Hypertensive Patient. [PDF]

Case Rep Med, 2018
Alcalde Dominguez A, Rabasa Antonijuan J, Cusidó Gimferrer M, Ortuño MJ.   +3 more
europepmc   +1 more source

The Use of Ulipristal Acetate (Esmya) Prior to Laparoscopic Myomectomy: Help or Hindrance? [PDF]

Gynecol Minim Invasive Ther, 2019
Mallick R, Oxley S, Odejinmi F.
europepmc   +1 more source

Ulipristal acetate for Japanese women with symptomatic uterine fibroids: A double-blind, randomized, phase II dose-finding study. [PDF]

Reprod Med Biol, 2020
Irahara M, Maejima Y, Shinbo N, Yamauchi Y, Mizunuma H.   +4 more
europepmc   +1 more source

The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor.

J Clin Endocrinol Metab, 2020
Small B, Millard CEF, Kisanga EP, Burman A, Anam A, Flannery C, Al-Hendy A, Whirledge S.   +7 more
europepmc   +1 more source